| 2024 | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 218,5 k € | +33.3% | 163,9 k € | -6.7% | 175,6 k € | +32.4% | 132,7 k € | +18.5% | 112,0 k € | +43.9% | 77,8 k € | -96.8% | 2,5 M € | -0.1% | 2,5 M € | +3.2% | 2,4 M € | +6.5% | 2,2 M € | +11.8% | 2,0 M € | -1.2% | 2,0 M € | +20.7% | 1,7 M € | +16.8% | 1,4 M € | -13.7% | 1,7 M € | +12.9% | 1,5 M € | +10.2% | 1,3 M € | +11.6% | 1,2 M € | |
| EBITDA | 184,8 k € | -76.1% | 772,2 k € | +193.4% | 263,2 k € | -61.1% | 676,7 k € | +204.6% | -647,0 k € | +42.6% | -1,1 M € | -261.9% | 696,5 k € | -57.4% | 1,6 M € | +6.5% | 1,5 M € | +6782.7% | 22,3 k € | +426.2% | -6,8 k € | -106.7% | 102,6 k € | +295.6% | -52,5 k € | -188.6% | 59,2 k € | -83.1% | 349,6 k € | +61.7% | 216,3 k € | +72.7% | 125,2 k € | -36.1% | 196,0 k € | |
| Operating profit | 140,6 k € | -80.8% | 734,0 k € | +285.9% | 190,2 k € | -69.5% | 624,3 k € | +189.6% | -696,7 k € | +40.7% | -1,2 M € | -279.6% | 654,1 k € | -58.7% | 1,6 M € | +7.0% | 1,5 M € | +7255.0% | -20,7 k € | +46.5% | -38,7 k € | -153.5% | 72,4 k € | +181.7% | -88,5 k € | -537.3% | 20,2 k € | -93.5% | 313,5 k € | +71.5% | 182,7 k € | +99.1% | 91,8 k € | -45.1% | 167,1 k € | |
| Profit/loss | 36,2 k € | -91.3% | 418,9 k € | +280.0% | 110,2 k € | -80.8% | 575,4 k € | +174.9% | -768,5 k € | +34.7% | -1,2 M € | -282.4% | 644,8 k € | -58.9% | 1,6 M € | +12.2% | 1,4 M € | +5397.9% | -26,4 k € | +24.6% | -35,0 k € | -162.7% | 55,8 k € | +166.3% | -84,3 k € | -1077.2% | 8,6 k € | -95.7% | 200,0 k € | +71.2% | 116,8 k € | +118.5% | 53,4 k € | -47.7% | 102,2 k € | |
| Equity | 1,3 M € | +2.8% | 1,3 M € | +48.4% | 866,0 k € | -22.8% | 1,1 M € | +105.2% | 547,1 k € | -58.4% | 1,3 M € | -67.0% | 4,0 M € | +19.3% | 3,3 M € | +88.4% | 1,8 M € | +370.5% | 377,6 k € | -6.5% | 404,0 k € | -8.0% | 439,0 k € | +14.6% | 383,2 k € | -18.0% | 467,4 k € | +1.9% | 458,8 k € | +77.3% | 258,8 k € | -24.3% | 342,0 k € | +18.5% | 288,6 k € | |
| Total assets | 2,7 M € | -49.8% | 5,4 M € | +21.5% | 4,5 M € | +91.8% | 2,3 M € | +27.0% | 1,8 M € | -59.5% | 4,5 M € | -10.9% | 5,1 M € | +13.0% | 4,5 M € | +89.3% | 2,4 M € | +157.5% | 919,3 k € | +5.4% | 872,5 k € | -3.1% | 900,8 k € | +16.5% | 773,3 k € | -7.6% | 837,3 k € | +8.8% | 769,2 k € | +0.8% | 763,0 k € | +30.6% | 584,4 k € | -0.4% | 586,7 k € | |
| Cash | 337,8 k € | -50.2% | 678,1 k € | +151.8% | 269,3 k € | -72.5% | 978,6 k € | +3.8% | 942,6 k € | -57.6% | 2,2 M € | -50.8% | 4,5 M € | +5342.3% | 83,1 k € | +851.3% | 8,7 k € | -81.2% | 46,6 k € | +110.0% | 22,2 k € | +0.6% | 22,0 k € | -17.9% | 26,9 k € | +74.9% | 15,4 k € | -62.5% | 41,0 k € | -5.7% | 43,4 k € | -45.2% | 79,3 k € | +103.7% | 38,9 k € | |
| Debts | 1,2 M € | -71.6% | 4,1 M € | +14.8% | 3,6 M € | +200.2% | 1,2 M € | -6.0% | 1,3 M € | -59.2% | 3,1 M € | +193.3% | 1,1 M € | -5.7% | 1,1 M € | +94.3% | 574,9 k € | +9.3% | 526,2 k € | +12.4% | 468,0 k € | +1.4% | 461,5 k € | +18.4% | 389,9 k € | +5.5% | 369,7 k € | +22.1% | 302,7 k € | -39.0% | 496,5 k € | +104.9% | 242,3 k € | -18.7% | 298,1 k € | |
| Staff | 26,5 | 28,4 | 27,6 | 28,9 | 26,5 | 25 | 25,2 | 21,4 | 20,8 | 19,5 | 17,1 | 15,8 | 16 | 13,1 | 11,8 | 10,6 | 10,4 | 9,2 | ||||||||||||||||||
Public limited company · Gent · incorporated on 23/11/1998 · 26,5 ETP
Public limited company profitable and well capitalised. Cash position declining (-50.2%).
Solid counterparty for a standard engagement.
NUTRITION SCIENCES is a Public limited company incorporated in 1998. Its main activity is: Technical testing and analysis. Its registered office is in Gent. It employs on average 26,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette